Cleared Traditional

K812484 - DAKO PAP KIT K505

K812484 is an FDA 510(k) clearance for DAKO PAP KIT K505, manufactured by Dako Corp.. The device is a Class 2 Pathology device with product code DEW cleared through the Traditional 510(k) pathway after a 163-day FDA review.

K812484 · Dako Corp. · Pathology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1982
Decision
163d
Days
Class 2
Risk

K812484 is an FDA 510(k) clearance for the DAKO PAP KIT K505. Classified as Igg, Antigen, Antiserum, Control (product code DEW), Class II - Special Controls.

Submitted by Dako Corp. (Mchenry, US). The FDA issued a Cleared decision on February 10, 1982 after a review of 163 days - an extended review cycle.

This device falls under the Pathology FDA review panel, regulated under 21 CFR 866.5510 - the FDA pathology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Pathology review framework, consistent with the majority of Class II 510(k) submissions.

View all Dako Corp. devices

FDA 510(k) Submission Details - K812484

510(k) Number K812484 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 31, 1981
Decision Date February 10, 1982
Days to Decision 163 days
Submission Type Traditional
Review Panel Pathology (PA)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
86d slower than avg
Panel avg: 77d · This submission: 163d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DEW Device Classification - Class 2, Special Controls

Product Code DEW Igg, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Pathology devices follow this clearance model.

Regulatory Peers - DEW Igg, Antigen, Antiserum, Control

All 57
Devices cleared under the same product code (DEW) and FDA review panel - the closest regulatory comparables to K812484.
TECH. RA-1000SYS-ANALYTES IMMUNOGLOBULIN
K833402 · Technicon Instruments Corp. · Jan 1984
TIA-IGG REAGENT & CALIBRATOR SETS
K831101 · Worthington Diagnostic Systems · Apr 1983
TITAN IMMUNO-FIX
K830594 · Helena Laboratories · Mar 1983
ACA IMMUNOGLOBULIN G ANALYTICAL TEST
K812664 · E.I. Dupont DE Nemours & Co., Inc. · Oct 1981
ACA IMMUNOGLOBULIN G CALIBRATOR
K812630 · E.I. Dupont DE Nemours & Co., Inc. · Sep 1981
IMMUNOGL. FRCT. OF RABBIT ANTISER.-IGG
K812489 · Dako Corp. · Sep 1981